WallStSmart
HURA

TuHURA Biosciences Inc

NASDAQ: HURA · HEALTHCARE · BIOTECHNOLOGY

$1.99
-5.69% today

Updated 2026-10-28

Market cap
$128.09M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.52
Dividend yield
—
52W range
$0 – $3
Volume
0.3M

WallStSmart proprietary scores

16
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
4.0
Quality
C
3.0
Profitability
D
5.0
Valuation
C+
1/9
Piotroski F-Score
Weak
-8.9
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →270 stocks currently score above 75

Price targets

Analyst target
$8.04
+304.02%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
2 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths
+ Debt/equity 0.02x — low leverage
Risks
- Piotroski 1/9 — weak financial health
- Altman Z -8.88 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-8.77M

Key financials

Revenue Net Income Free Cash Flow
Metric2023202420252026TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$-14.65M$-8.32M$-21.68M$-30.06M$-9.22M
EPS————$-0.52
Free cash flow$-7.54M$-12.03M$-14.79M$-27.71M$-8.77M
Profit margin—————

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
HURA$128.09M164.33.05.04.0—Avoid
LLY$1.12T769.310.05.06.0—Strong Buy
JNJ$615.87B574.78.52.75.5-83.05%Buy
ABBV$504.37B736.78.54.05.0-86.73%Strong Buy
UNH$360.32B626.76.04.75.5-25.92%Buy
MRK$360.08B364.04.52.05.0-73.68%Hold

Smart narrative

TuHURA Biosciences Inc trades at $1.99. Our Smart Value Score of 16/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -8.88, it sits in the distress.

Frequently asked questions

What is TuHURA Biosciences Inc's stock price?

TuHURA Biosciences Inc (HURA) trades at $1.99.

Is TuHURA Biosciences Inc overvalued?

TuHURA Biosciences Inc carries a Smart Value Score of 16/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of TuHURA Biosciences Inc (HURA)?

The 12-month analyst consensus target is $8.04, about 304.0% above the current $1.99. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

TuHURA Biosciences Inc's Altman Z-Score is -8.88, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio—
ROE-133.39%
Beta-0.84
50D MA$2.05
200D MA$1.93
Shares out0.06B
Float0.04B
Short ratio—
Avg volume0.3M

Performance

1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—